Physician profile
Martin Morrison
NPI 1326206335
$25,204.54
in general payments reported to CMS, 2019-2025
10 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $5,759 · 2021: $2,979 · 2022: $1,308 · 2023: $914 · 2024: $246 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160 · Travel and Lodging: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.18 |
| Travel and Lodging | $222.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $16,752.51 | 2019-2025 | |
| Medical Device Business Services, INC. | $5,494.21 | 2020-2023 | Expedium |
| Depuy Synthes Sales INC. | $1,168.61 | 2019-2022 | |
| Stryker Corporation | $696.92 | 2019-2022 | |
| Nuvasive, INC. | $401.33 | 2020-2023 | Reline, Tlif |
| Globus Medical, INC. | $235.42 | 2024-2025 | Reflect/Reflect Hde, Reline |
| Orthofix Medical, INC. | $219.72 | 2019-2023 | M6-C, Newbridge |
| Biedermann Motech, INC. | $179.71 | 2023 | Moss Vrs Spinal System |
| Biomarin Pharmaceutical INC. | $56.11 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.